Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects

NCT06119958 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Drug Interaction

Interventions

DRUG: DWC202313
DRUG: DWC202314

Sponsor

Daewoong Pharmaceutical Co. LTD.